BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 10317825)

  • 1. Speaking the language of financial management: a guide to analyzing costs.
    Valdiserri RO
    Pathologist; 1986 Nov; 40(11):31-3. PubMed ID: 10317825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision making in pathology: what is the impact of economic and technologic change?
    Davis GL
    Pathologist; 1985 Apr; 39(4):23-7. PubMed ID: 10317590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Better quality medicine at lowered costs by a cost effective laboratory service system (CELSS).
    Nalbandian RM; Henry RL
    Mich Med; 1981 Aug; 80(23):428-9. PubMed ID: 6790915
    [No Abstract]   [Full Text] [Related]  

  • 4. Directing the post-TEFRA laboratory.
    Sharp JW
    Pathologist; 1985 Feb; 39(2):15-8. PubMed ID: 10270443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zero base approach to fiscal management of the laboratory.
    Boudreau DA; Majonos JS
    Pathologist; 1985 Aug; 39(8):14-8. PubMed ID: 10272519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical audit. Putting pathology under the savings spotlight.
    Kerr C
    Health Soc Serv J; 1985 Dec; 95(4978):1576. PubMed ID: 10317686
    [No Abstract]   [Full Text] [Related]  

  • 7. Surviving prospective reimbursement: how computers can help contain lab costs.
    Aller RD
    Pathologist; 1985 Apr; 39(4):12-6. PubMed ID: 10317589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling compensation for hospital-based pathologists.
    Van Vorst CB
    Case Stud Health Adm; 1980; 2():317-22. PubMed ID: 10250520
    [No Abstract]   [Full Text] [Related]  

  • 9. Generating revenue through laboratory testing.
    Hannon F
    Hosp Entrep Newsl; 1987 Jun; 3(1):1-2, 8. PubMed ID: 10325197
    [No Abstract]   [Full Text] [Related]  

  • 10. In-house software monitors and projects costs.
    Sealfon MS
    MLO Med Lab Obs; 1987 Jan; 19(1):75-6. PubMed ID: 10280455
    [No Abstract]   [Full Text] [Related]  

  • 11. Algorithms and protocols for DRG testing.
    Marchand A
    MLO Med Lab Obs; 1987 Apr; 19(4):30-5. PubMed ID: 10317885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologists to challenge Medicare rule.
    Lewis R
    Am Med News; 1983 Apr; 26(14):1, 19. PubMed ID: 10324806
    [No Abstract]   [Full Text] [Related]  

  • 13. The unordered test: cost of the benefit vs. benefit of the cost.
    Winkelman JW; Bernstein LH
    Pathologist; 1985 Jul; 39(7):12-6. PubMed ID: 10317618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legal considerations in pathologists' contracting-recent developments.
    Polk LT
    Pathologist; 1981 May; 35(5):268-71. PubMed ID: 10251158
    [No Abstract]   [Full Text] [Related]  

  • 15. Analyzing the factors contributing to rising laboratory costs.
    Tydeman J; Morrison JI; Cassidy PA; Hardwick DF
    Arch Pathol Lab Med; 1983 Jan; 107(1):7-12. PubMed ID: 6401206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is that new instrument a winner?
    Stafford AC
    MLO Med Lab Obs; 1986 Apr; 18(4):24-8. PubMed ID: 10317714
    [No Abstract]   [Full Text] [Related]  

  • 17. Economics as a tool in managerial decision making.
    Hayes TJ
    Radiol Manage; 1979; 2(1):13-5. PubMed ID: 10244739
    [No Abstract]   [Full Text] [Related]  

  • 18. What the regulatory developments mean for pathologist-hospital contracts.
    Bierig JR; Dechene JC
    Pathologist; 1984 Sep; 38(9):562-7. PubMed ID: 10273568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis: strep only culture.
    McConnell TS; Fuller WD
    Rocky Mt Med J; 1978; 75(4):207-8. PubMed ID: 356166
    [No Abstract]   [Full Text] [Related]  

  • 20. An on-line cost analysis system.
    Whitehouse CR
    MLO Med Lab Obs; 1984 Mar; 16(3):115-20. PubMed ID: 10265402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.